HK1006273A1 - Pharmaceutical compositions based on ebastine or analogues thereof - Google Patents

Pharmaceutical compositions based on ebastine or analogues thereof

Info

Publication number
HK1006273A1
HK1006273A1 HK98105265A HK98105265A HK1006273A1 HK 1006273 A1 HK1006273 A1 HK 1006273A1 HK 98105265 A HK98105265 A HK 98105265A HK 98105265 A HK98105265 A HK 98105265A HK 1006273 A1 HK1006273 A1 HK 1006273A1
Authority
HK
Hong Kong
Prior art keywords
pct
ebastine
analogues
pharmaceutical compositions
compositions based
Prior art date
Application number
HK98105265A
Other languages
English (en)
Inventor
Jean-Marc Bobee
Guillaume Conrath
Gabriel Gousset
Michel Ponsot
Michel Veillard
Original Assignee
Rhone Poulenc Rores S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9419600&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006273(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rores S A filed Critical Rhone Poulenc Rores S A
Publication of HK1006273A1 publication Critical patent/HK1006273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
HK98105265A 1991-12-03 1998-06-13 Pharmaceutical compositions based on ebastine or analogues thereof HK1006273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114936A FR2684298B1 (fr) 1991-12-03 1991-12-03 Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
PCT/FR1992/001116 WO1993010782A1 (fr) 1991-12-03 1992-12-01 Compositions pharmaceutiques a base d'ebastime ou de ses analoques

Publications (1)

Publication Number Publication Date
HK1006273A1 true HK1006273A1 (en) 1999-02-19

Family

ID=9419600

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105265A HK1006273A1 (en) 1991-12-03 1998-06-13 Pharmaceutical compositions based on ebastine or analogues thereof

Country Status (12)

Country Link
US (1) US5460829A (xx)
EP (1) EP0614362B1 (xx)
JP (1) JP3518601B2 (xx)
AT (1) ATE148990T1 (xx)
CA (1) CA2123232C (xx)
DE (1) DE69217554T2 (xx)
DK (1) DK0614362T5 (xx)
ES (1) ES2097490T3 (xx)
FR (1) FR2684298B1 (xx)
GR (1) GR3022615T3 (xx)
HK (1) HK1006273A1 (xx)
WO (1) WO1993010782A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717025A (en) * 1996-09-16 1998-02-10 H. B. Fuller Licensing & Financing, Inc. Melamine-formaldehyde resin based adhesive compositions
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
WO2002100339A2 (en) 2001-06-13 2002-12-19 Biogal Gyogyszergyar Rt. Novel process for preparing rac-bicalutamide and its intermediates
CA2478897A1 (en) * 2002-03-12 2003-09-18 Y's Therapeutics Co., Limited Compounds capable of inhibiting immunocyte-related allergic immune reactions
TWI286942B (en) * 2002-06-10 2007-09-21 Dainippon Sumitomo Pharma Co Rapidly disintegrating tablet and preparing method thereof
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
ES2231043B2 (es) * 2004-10-29 2005-10-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
DE602005000992D1 (de) * 2005-04-25 2007-06-06 Alter Lab Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat
EP1898882B1 (en) * 2005-06-09 2009-10-28 Elan Pharma International Limited Nanoparticulate ebastine formulations
ES2277767B1 (es) * 2005-11-04 2008-04-01 Simbec Iberica, S.L. Formas orales solidas de ebastina.
JP2007297348A (ja) * 2006-05-02 2007-11-15 Daito Kk エバスチンを含有する錠剤
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102008000351B4 (de) 2008-02-20 2017-08-10 Aristo Pharma Gmbh Verfahren zur Herstellung eines Ebastin enthaltenden Granulats sowie einer festen pharmazeutischen Zusammensetzung, Ebastin enthaltendes Granulat und dessen Verwendung
DE202011000756U1 (de) 2011-03-31 2011-10-12 Micro Labs Limited Ebastine, nicht-mikronisierte Ebastinepartikel und pharmazeutische Zusammensetzungen umfassend Ebastine
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine
WO2013062498A1 (en) * 2011-10-13 2013-05-02 Mahmut Bilgic Solid oral formulations comprising ebastine
EP2589376B1 (en) 2011-11-01 2016-09-21 Inopharm Limited Oral disintegrating composition of anti-histamine agents
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105326802A (zh) * 2015-09-01 2016-02-17 杭州澳医保灵药业有限公司 一种依巴斯汀分散片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
EP0402422A1 (en) * 1988-04-27 1990-12-19 Schering Corporation Certain paf antagonist antihistamine combinations and methods
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations

Also Published As

Publication number Publication date
WO1993010782A1 (fr) 1993-06-10
DE69217554D1 (de) 1997-03-27
FR2684298B1 (fr) 1994-03-11
FR2684298A1 (fr) 1993-06-04
JP3518601B2 (ja) 2004-04-12
US5460829A (en) 1995-10-24
DK0614362T5 (da) 2008-11-10
EP0614362A1 (fr) 1994-09-14
GR3022615T3 (en) 1997-05-31
EP0614362B1 (fr) 1997-02-19
CA2123232A1 (fr) 1993-06-10
JPH07501533A (ja) 1995-02-16
CA2123232C (fr) 2005-02-15
ATE148990T1 (de) 1997-03-15
ES2097490T3 (es) 1997-04-01
DK0614362T3 (da) 1997-03-10
DE69217554T2 (de) 1997-08-07

Similar Documents

Publication Publication Date Title
HK1006273A1 (en) Pharmaceutical compositions based on ebastine or analogues thereof
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
BG104877A (en) N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
BG104819A (en) Substituted indolealkanoic acids
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
AU3563695A (en) Novel piperidine derivatives with paf antagonist activity
HK1019010A1 (en) Preparation of n-acetyl neuraminic derivatives
IL113178A (en) 8alpha-3-hydroxyestra-1,3,5(11)tetraen-17-one( 9(11)-dehydro-8-isoestrone) its preparation and pharmaceutical composition containing it
HU912486D0 (en) Process for producing ethers and thioethers of piperidyl
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
SG46649A1 (en) Compositions
PL308580A1 (en) Solid pharmaceutical composition for oral administration and method of preparing same
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use
EP0530016A3 (en) Piperidine derivative and pharmaceutical composition containing it
IL100889A (en) Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20121130